Low-dose natural antimicrobial exacerbates chronic lung infection in cystic fibrosis
Friday, April 25, 2014 - 11:01
in Health & Medicine
Respiratory failure caused by chronic lung infection with Pseudomonas aeruginosa bacteria is a common cause of death in patients with cystic fibrosis, a genetic disease that is common in individuals of European descent. A new study demonstrates that an antimicrobial peptide produced by human immune cells can promote mutations in the bacterium that make it more lethal.